ArticleVaccines2025

Neutralization Activity of Standard and Hyperimmune Intravenous Immunoglobulins Against Recently Circulating SARS-CoV-2 Variants.

Dongxiao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.